Echinacea Myrciaria Synergistic Composition for Flu Duration Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-flu compositions are ineffective in significantly shortening the duration of flu infections and often come with undesirable side effects, limiting their use, especially in individuals with chronic conditions.
Innovation Solution
A synergistic composition of dry extracts from Echinacea purpurea and Myrciaria dubia, with a weight ratio of 4% to 40% Myrciaria dubia and 30% to 80% Echinacea purpurea, which includes metabolites like ellagic acid, cichoric acid, and quercetin, effectively reduces the duration of flu infections to 3-4 days without adverse effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional anti-flu compositions are used, then immune response is stimulated, but the duration of flu infection is not significantly reduced and side effects occur
Solution Approach 1:
The patent combines extracts from two different plant sources - Echinacea purpurea (providing alkylamides and phenolic compounds) and Myrciaria dubia (providing high concentration of vitamin C and ellagic acid). This synergistic combination achieves both significant reduction in flu duration (70% reduction to 3-4 days) and elimination of side effects, resolving the technical contradiction between efficacy and safety
2Reliability
If higher concentration of active ingredients is used to improve efficacy, then immune stimulation increases, but harmful side effects increase
Solution Approach 1:
The patent optimizes the concentration parameters of active ingredients within specific ranges: alkylamides at 0.1-10 mg/g, phenolic compounds at 0.5-5.0 mg/g, and vitamin C at 50-500 mg/100g. These controlled parameter changes achieve potent immune stimulation while maintaining safety by avoiding toxic concentrations, thus resolving the contradiction between efficacy and harmful effects
3Loss of time
If traditional flu treatments are used, then symptoms are managed, but the duration of infection remains prolonged at 10-15 days
Solution Approach 1:
The patent employs alkylamides from Echinacea purpurea which act as preliminary immunostimulants, activating immune defenses before the virus can establish full infection. This preliminary immune activation, combined with the antioxidant protection from vitamin C and ellagic acid, prevents viral progression and shortens infection duration to 3-4 days, significantly reducing the 10-15 day duration of traditional treatments
Data Source
Figure 1
Figure 2
AI summary
The invention relates to a composition from the extract of Myrciaria dubia and Echinacea purpurea, which has a synergistic effect. The composition of the invention has potentiated antioxidant and anti-flu properties, as well as a high immuno-stimulating capacity.